Infection rates in HIV-HCV patients treated with interferon are similar to those in HCV mono-infection and not related to neutropenia

HIV Clinical Trials

Volumn 7, Issue 5, 2006, Pages 251-254

  Cooper, Curtis L ^a   Al Bedwawi, Saif ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

HCV; HIV; Infection; Interferon; Neutropenia

Indexed keywords

ALPHA2B INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; HEALTH STATUS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; MALE; NEUTROPENIA; NEUTROPHIL COUNT; PREDICTION; PRIORITY JOURNAL; SUPERINFECTION;

EID: 33845688695     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/hct0705-251     Document Type: Article

References (9)

1. Meynard JL, Guiguet M, Arsac S, Frottier J, Meyohas MC. Frequency and risk factors of infectious complications in neutropenic patients infected with HIV. AIDS. 1997;11:995-998.
2. Levine AM, Karim R, Mack W, et al. Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study. Arch Intern Med. 2006;166:405-410.
3. Armstrong WS, Kazanjian P. Use of cytokines in human immunodeficiency virus-infected patients: colony-stimulating factors, erythropoietin, and interleukin-2. Clin Infect Dis. 2001;32:766-773.
4. Tien PC. Management and treatment of hepatitis C virus infection in HIV-infected adults: recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office. Am J Gastroenterol. 2005:100:2338-2354.
5. Collantes RS, Younossi ZM. The use of growth factors to manage the hematologic side effects of PEG-interferon alfa and ribavirin. J Clin Gastroenterol. 2005;39:S9-13.
6. Cooper CL, Al-Bedwawi S, Lee C, Garber G. Rate of infectious complications during interferon-based therapy for hepatitis C is not related to neutropenia. Clin Infect Dis. 2006;42:1674-1678.
7. Soza A, Everhard JE, Ghany MG, et al. Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C. Hepatology. 2002:1273-1279.
8. Puoti M, Babudieri S, Rezza G, et al. Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? Antivir Ther. 2004;9:627-630.
9. Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, and Infectious Diseases Society of America, and the American Society of Blood and Marrow. Transplantation. 2000;49:RR-10.